Literature DB >> 10496307

Endogenous IL-15 might be responsible for early protection by natural killer cells against infection with an avirulent strain of Salmonella choleraesuis in mice.

K Hirose1, H Nishimura, T Matsuguchi, Y Yoshikai.   

Abstract

Interleukin (IL)-15 is a novel cytokine with growth factor activity for T cells, B cells, and natural killer cells (NK cells). We investigated the role of IL-15 in the host defense against infection with avirulent Salmonella choleraesuis strain 31N-1 cured of 50-kb virulent plasmid. IL-15 was abundantly expressed at transcription and protein levels in macrophages infected with S. choleraesuis 31N-1. The number of NK cells in the infected sites was increased during the course of infection coincident with IL-15 production. Anti-IL-15 mAb administration inhibited the emergence of NK cells and interferon-gamma (IFN-gamma) production in serum after infection with S. choleraesuis 31N-1 and concurrently impaired the clearance of the bacteria. These results suggested that IL-15 might be responsible for protection against avirulent S. choleraesuis infection at early stage of infection through activation of NK cells in the infected sites.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10496307     DOI: 10.1002/jlb.66.3.382

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  18 in total

Review 1.  A dynamic view of the spread and intracellular distribution of Salmonella enterica.

Authors:  Pietro Mastroeni; Andrew Grant; Olivier Restif; Duncan Maskell
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

Review 2.  The interaction of intestinal epithelial cells and intraepithelial lymphocytes in host defense.

Authors:  Y Yoshikai
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  Mice lacking interleukin-2 (IL-2)/IL-15 receptor beta chain are susceptible to infection with avirulent Salmonella enterica subsp. enterica serovar choleraesuis but mice lacking IL-2 are resistant.

Authors:  H Nishimura; M Tagaya; H Tsunobuchi; H Suzuki; I Nakashima; Y Yoshikai
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 4.  Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Authors:  Fernando Souza-Fonseca-Guimaraes; Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

5.  Interleukin-15 enhances innate and adaptive immune responses to blood-stage malaria infection in mice.

Authors:  Rebecca Ing; Philippe Gros; Mary M Stevenson
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 6.  Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment.

Authors:  Cheng-Hsun Chiu; Lin-Hui Su; Chishih Chu
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo.

Authors:  Simone Haeberlein; Heidi Sebald; Christian Bogdan; Ulrike Schleicher
Journal:  Eur J Immunol       Date:  2010-06       Impact factor: 5.532

8.  Early interferon-γ production in human lymphocyte subsets in response to nontyphoidal Salmonella demonstrates inherent capacity in innate cells.

Authors:  Tonney S Nyirenda; Anna E Seeley; Wilson L Mandala; Mark T Drayson; Calman A MacLennan
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

9.  Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture.

Authors:  Sunwoong S Choi; Vaninder S Chhabra; Quoc H Nguyen; Bonnie J Ank; E Richard Stiehm; Robert L Roberts
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

10.  Virulent Salmonella enterica infections can be exacerbated by concomitant infection of the host with a live attenuated S. enterica vaccine via Toll-like receptor 4-dependent interleukin-10 production with the involvement of both TRIF and MyD88.

Authors:  Gemma L Foster; Tom A Barr; Andrew J Grant; Trevelyan J McKinley; Clare E Bryant; Andrew MacDonald; David Gray; Masahiro Yamamoto; Shizuo Akira; Duncan J Maskell; Pietro Mastroeni
Journal:  Immunology       Date:  2008-02-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.